Home > Products > IL13 & IL17 > Recombinant Anti-IL13 x Anti-IL17 Bispecific Antibody (scFv-Fc)

Recombinant Anti-IL13 x Anti-IL17 Bispecific Antibody (scFv-Fc)  (CAT#: BSCFV-172)

Recombinant Anti-IL13 x Anti-IL17 Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-IL13 specificity or anti-IL17 specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Asthma therapy.
Datasheet INQUIRY

Specifications

Targets
IL13 & IL17
Type
scFv-based Bispecific Fragments
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Asthma

Targets

Target 1
IL13
Gene ID
UniProt ID
Alternative Names
IL13; interleukin 13; P600; IL-13; interleukin-13
Target 2
IL17
Gene ID
UniProt ID
Alternative Names
IL17A; interleukin 17A; IL17; CTLA8; IL-17; IL-17A; interleukin-17A; CTLA-8; cytotoxic T-lymphocyte-associated antigen 8; cytotoxic T-lymphocyte-associated protein 8; interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8)
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "IL13 & IL17"
See other bsAb targets related to "IL17"

See other bsAb targets related to "IL13"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-IL13 x Anti-IL17 Bispecific Antibody (scFv-Fc) (BSCFV-172). Click the button below to contact us or submit your feedback about this product.